F&B industry executives should be mindful of their PFAS litigation exposure and consult with specialized legal counsel to take steps to both avoid and prepare for litigation.
In her practice, author Stephanie Salek has represented pharmaceutical, automotive, oil, and consumer products companies in products liability and toxic tort litigation.
by Robert Johnston and Shannon Proctor
Firm attorney Varun Aery writes that defendants should highlight any misjoinder in removal papers.
Andrew Reissaus and Alexandra Stubblefield follow up on their previous article regarding the OTC decongestants MDL.
Food industry businesses should be especially proactive in addressing potential liability before companies' mandatory reports on PFAS use become public.
Andrew Reissaus and Alexandra Stubblefield authored the legal opinion letter for Washington Legal Foundation.
Firm Partner Carter Thurman Serves as a Featured Expert Contributor on Litigation Strategies for Washington Legal Foundation
Stephanie Salek explains that blending mandatory rules with flexible opportunities fosters learning, collaboration, and relationship-building.
David Schifrin and Melissa Baney write that introducing evidence of bans or restrictions risks creating unfair prejudice, confusing the jury, and wasting time.
Firm partner Carter Thurman serves as a Featured Expert Contributor on Litigation Strategies for the Washington Legal Foundation Legal Pulse blog.
Firm partner Louis Russo examines lower-level detection in torts and offers strategic advice on litigating a dose case.
Grant Hollingsworth and Brett Covington share agreement drafting tips and advise that including key terms can avoid costly litigation.
Two recent opinions illustrate how pivotal courts' views on standing will be for product liability litigation involving PFAS — particularly consumer claims.
Firm partners Gary Feldon, Matthew Malinowski, and Sebastian Ovalle analyze the impact of the end of Chevron deference.
